Your shopping cart is currently empty

UDP trisodium (Compound 3) is a nucleotide and a P2Y14 receptor agonist, exhibiting an EC50 of 160 nM for the human P2Y14 receptor. It demonstrates greater efficacy compared to the P2Y6 receptor and is utilized in researching pain, diabetes, cystic fibrosis, and other pulmonary disorders.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | UDP trisodium (Compound 3) is a nucleotide and a P2Y14 receptor agonist, exhibiting an EC50 of 160 nM for the human P2Y14 receptor. It demonstrates greater efficacy compared to the P2Y6 receptor and is utilized in researching pain, diabetes, cystic fibrosis, and other pulmonary disorders. |
| Targets&IC50 | P2Y14 receptor (human):160 nM (EC50) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.